Innovative Clinical Approach in Biosimilars

Clinical trials for biosimilars must exhibit practically identical security what's more, viability to the reference item, including consecutive PK/ PD and viability/security trials. Controllers expect PK/PD similarity information from a Phase I trial will bolster encourage viability/ wellbeing evaluations in crucial Phase III trials. Remain solitary Phase III investigations or joined Phase I/III outlines without supporting PK information are probably not going to be acknowledged. Clinical similarity prerequisites may fluctuate on a case-by-case premise subject to a risk based approach. Three-arm Phase I trials are progressively being used to show equivalence between the biosimilars and two authorized adaptations of a similar reference item that may exist in various markets, allowing developers to proceed with pivotal trials using a single version of the reference product

  • Biosimilars clinical trials
  • Clinical PK/PD studies
  • Toxicological studies
  • Risk management and quality affairs
  • Risk management and quality affairs
  • Targeted cell line development
  • Case studies and clinical models
  • Biologics product life cycle and sustainable market returns

Related Conference of Innovative Clinical Approach in Biosimilars

August 28-29, 2018

10th World Congress on Neuropharmacology

Paris, France
September 13-14, 2018

8th World Congress on Chromatography

Prague, Czech Republic | Panorama Hotel Prague | Milevská 7, 140 63 Praha
September 17-18, 2018

15th International Conference on Pharmaceutical Formulations & Drug Delivery

| Philadelphia, Pennsylvania, USA
September 20-22, 2018

17th Annual Congress on Pharmaceutics & Drug Delivery Systems

Prague, Czech Republic | Panorama Hotel Prague | Milevská 7, 140 63 Praha
September 24-25, 2018

Middle East Pharmacy and Pharmaceutical Conference

Abu Dhabi, UAE
September 24-26, 2018

12th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
September 24-26, 2018

7th International Conference on Clinical Trials

| Chicago, Illinois, USA
(10 Plenary Forums - 1 Event)
September 26-27, 2018

5th International Conference on Clinical Pharmacy and
Health Care

San Antonio, Texas, USA
September 28-29, 2018

11th World Congress on Pharmaceutical Sciences

| Montreal, Canada
October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
November 05-07, 2018

18th Annual Pharma Middle East Congress

Abu Dhabi, UAE
November 08-09, 2018

17th World Congress on Drug Formulation & Drug Delivery

Auckland, New Zealand
November 14-15, 2018

13th World Congress on Pharmacology and Toxicology

Melbourne, Australia
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Berlin, Germany
November 16-17, 2018

5th Annual Congress on Clinical & Hospital Pharmacy

Tokyo, Japan
February 28-March 01, 2019

Global Pharmaceutical & Pharma Industry Conference

Osaka, Japan
Feb 28-March 01, 2019

International Conference on Bio-Pharmaceuticals

Osaka, Japan
April 22-23, 2019

6th World Congress on Drug Discovery & Toxicology

Abu Dhabi, UAE
March 22-23, 2019

5th International Conference on Antibiotics

Chicago, Illinois, USA
March 25-26, 2019

World Congress on Pharmaceutical Biotechnology & Bioengineering

Orlando, Florida, USA
April 15-16, 2019

12th European Biosimilars Congress

Berlin, Germany
April 17-18, 2019

11th World Congress on Pharmacology & Therapeutics

Montreal, Canada
April 17-18, 2019

Annual Neurochemistry and Neuropharmacology Congress

| Montreal, Canada
May 15-17, 2019

4th Annual Congress on Nanomedicine and Drug Delivery

Hyatt Regency Osaka, Japan
May 20-21, 2019

21st Annual European Pharma Congress

Zurich, Switzerland
April 22-24, 2019

20th Asia-Pacific Pharma Congress

Tokyo, Japan
September 11-13, 2019

8th International Conference on Clinical Trials

| Orlando, Florida, USA

Innovative Clinical Approach in Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in